Long Run Wealth Advisors’s Boston Scientific BSX Stock Holding History

Long Run Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$3.84M	Buy	40,224 +605	+2%	+$59.3K	0.72%	38
2025 Q3	$3.87M	Buy	39,619 +3,060	+8%	+$317K	0.76%	38
2025 Q2	$3.93M	Sell	36,559 -624	-2%	-$63.1K	0.82%	33
2025 Q1	$3.75M	Sell	37,183 -2,536	-6%	-$255K	0.85%	31
2024 Q4	$3.55M	Sell	39,719 -3,624	-8%	-$319K	0.85%	39
2024 Q3	$3.63M	Sell	43,343 -5,218	-11%	-$411K	0.86%	36
2024 Q2	$3.74M	Buy	+48,561	New	+$3.55M	0.95%	30

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Long Run Wealth Advisors's BSX Position: Q4 2025 in Review

Long Run Wealth Advisors increased its Boston Scientific (BSX) stake by 1.5% in Q4 2025, buying an estimated $59.3K and bringing the position to 40,224 shares worth $3.84M. The position accounts for 0.72% of the portfolio, ranked #38.

Long Run Wealth Advisors first reported a position in BSX in Q2 2024 and has held it in 7 quarters since. The position peaked at $3.93M in Q2 2025. 1,783 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Long Run Wealth Advisors held 40,224 shares of Boston Scientific worth $3.84M as of Q4 2025.
Long Run Wealth Advisors bought 605 Boston Scientific shares in Q4 2025, an estimated $59.3K.
Boston Scientific made up 0.72% of Long Run Wealth Advisors's portfolio in Q4 2025, its #38 holding.
Long Run Wealth Advisors first reported a position in Boston Scientific in Q2 2024 and has held it in 7 quarters since.
Long Run Wealth Advisors's Boston Scientific position peaked at $3.93M in Q2 2025.
1,783 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Long Run Wealth Advisors's 13F filing for Q4 2025, filed 2 Feb 2026.